ID: ALA355518

Max Phase: Preclinical

Molecular Formula: C8H16ClNO2

Molecular Weight: 158.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[N+]1(C)CCCCC1C(=O)O.[Cl-]

Standard InChI:  InChI=1S/C8H15NO2.ClH/c1-9(2)6-4-3-5-7(9)8(10)11;/h7H,3-6H2,1-2H3;1H

Standard InChI Key:  MTHUYCKWLYBVJP-UHFFFAOYSA-N

Associated Targets(non-human)

Carnitine/acylcarnitine translocase 26 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 158.22Molecular Weight (Monoisotopic): 158.1176AlogP: 0.70#Rotatable Bonds: 1
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.39CX Basic pKa: CX LogP: -3.43CX LogD: -2.66
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.57Np Likeness Score: 1.70

References

1. Woster PM, Murray WJ..  (1986)  Synthesis and biological evaluation of cyclic analogues of 1-carnitine as potential agents in the treatment of myocardial ischemia.,  29  (5): [PMID:3084787] [10.1021/jm00155a045]

Source